
A designed antifungal peptide with therapeutic potential for scientific drug-resistant Candida albicans
Because of the growing drug-resistant of Candida albicans (C. albicans), there’s an pressing must develop a novel therapeutic agent for C. albicans induced inflammatory illness remedy. Antimicrobial peptides (AMPs) are considered one of the vital promising antifungal medicine.
Nonetheless, a lot of the designed AMPs confirmed side-effects. Within the current research, 10 novel peptides have been designed based mostly on the sequence of frog pores and skin secretions peptide (Ranacyclin AJ). Amongst them, AKK8 (RWRFKWWKK) exhibited the strongest antifungal impact towards each customary and clinically remoted drug-resistant C. albicans. AKK8 killed C. albicans (inside 30 min), and the antifungal impact lasted for 24 h, confirmed an environment friendly and lengthy lasted antifungal impact towards C. albicans.
Notably, AKK8 confirmed low toxicity to human purple blood cells and excessive stability in human serum. Furthermore, AKK8 administration confirmed therapeutic results on systemic infections mice induced by the scientific drug-resistant C. albicans, in a dose-depended method. These findings recommended that AKK8 could also be a possible candidate for the anti-inflammation therapies for ailments attributable to scientific drug-resistant C. albicans.

antibodysource
Disp2 Peptide |
|||
MBS151984-5x005mg | MyBiosource | 5x0.05mg | 770 EUR |
AAP94825-100UG - Disp2 Blocking peptide (C terminal region) |
|||
AAP94825-100UG | Aviva Systems Biology | 100ug | 99 EUR |
Mast Cell-Degranulating Peptide (MCD Peptide) / Peptide 401 |
|||
004-04 | PHOENIX PEPTIDE | 100 μg | 140.4 EUR |
Peptide T |
|||
057-01 | PHOENIX PEPTIDE | 5 mg | 140.4 EUR |
FGL Peptide |
|||
073-36 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
APK peptide |
|||
076-81 | PHOENIX PEPTIDE | 200 μg | 199.8 EUR |
NEF peptide |
|||
076-83 | PHOENIX PEPTIDE | 500 μg | 140.4 EUR |
SHA peptide |
|||
076-84 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
YSY peptide |
|||
076-86 | PHOENIX PEPTIDE | 100 μg | 230.04 EUR |
Peptide E / 3200-Dalton Adrenal Enkephalin-Containing Peptide (Bovine) |
|||
024-57 | PHOENIX PEPTIDE | 200 μg | 86.4 EUR |
PSTAIR Peptide |
|||
070-61 | PHOENIX PEPTIDE | 500 μg | 129.6 EUR |
PGMtide Peptide |
|||
040-69 | PHOENIX PEPTIDE | 100 μg | 316.44 EUR |
Adjuvant Peptide |
|||
070-05 | PHOENIX PEPTIDE | 500 μg | 36.72 EUR |
Peptide-epsilon |
|||
058-22 | PHOENIX PEPTIDE | 500 μg | 114.48 EUR |
Delicious Peptide |
|||
070-21 | PHOENIX PEPTIDE | 5 mg | 160.92 EUR |
proSex peptide (20-55) |
|||
040-30 | PHOENIX PEPTIDE | 100 μg | 355.32 EUR |
proSex peptide (28-55) |
|||
040-31 | PHOENIX PEPTIDE | 100 μg | 282.96 EUR |
proSex peptide (40-55) |
|||
040-32 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Bombinin-Like Peptide 1 amide / prepro-Bombinin-Like Peptide (44-70) amide / prepro-Bombinin-Like Peptide (107-133) amide |
|||
007-60 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Peptide F-9 |
|||
038-06 | PHOENIX PEPTIDE | 200 μg | 58.32 EUR |
Sturgeon Peptide (137-158) |
|||
021-94 | PHOENIX PEPTIDE | 100 μg | 177.12 EUR |
Peptide Lv (Rat) |
|||
008-73 | PHOENIX PEPTIDE | 100 μg | 469.8 EUR |
NGR Peptide 1 |
|||
025-74 | PHOENIX PEPTIDE | 200 μg | 184.68 EUR |
Anorexigenic Peptide |
|||
070-10 | PHOENIX PEPTIDE | 5 mg | 86.4 EUR |
GnRH Associated Peptide (GAP) (1-13) / GnRH Precursor Peptide (14-26) (Human) |
|||
029-03 | PHOENIX PEPTIDE | 500 μg | 114.48 EUR |
GnRH Associated Peptide (GAP) (1-24) / GnRH Precursor Peptide (14-37) (Human) |
|||
029-04 | PHOENIX PEPTIDE | 100 μg | 114.48 EUR |
GnRH Associated Peptide (GAP) (1-53) / GnRH Precursor Peptide (14-66) (Human) |
|||
029-05 | PHOENIX PEPTIDE | 20 μg | 267.84 EUR |
GnRH Associated Peptide (GAP) (25-53) / GnRH Precursor Peptide (38-66) (Human) |
|||
029-06 | PHOENIX PEPTIDE | 100 μg | 114.48 EUR |
Bid BH3 peptide |
|||
025-87 | PHOENIX PEPTIDE | 1 mg | 170.64 EUR |
AF-16 Peptide |
|||
033-44 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Peptide Lv (Human) |
|||
008-71 | PHOENIX PEPTIDE | 100 μg | 405 EUR |
Peptide Lv (Mouse) |
|||
008-72 | PHOENIX PEPTIDE | 100 μg | 469.8 EUR |
GnRH Associated Peptide (GAP) (1-13) / Gn-RH Precursor Peptide (14-26) (Rat) |
|||
029-08 | PHOENIX PEPTIDE | 200 μg | 64.8 EUR |
ExE peptide M3mP6 |
|||
064-33 | PHOENIX PEPTIDE | 200 μg | 244.08 EUR |
Peptide B (Bovine) |
|||
024-56 | PHOENIX PEPTIDE | 200 μg | 81 EUR |
Peptide F (Bovine) |
|||
024-58 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
PLP Peptide (103-116) (Bovine) |
|||
070-14 | PHOENIX PEPTIDE | 5 mg | 140.4 EUR |
FMRF-Like Peptide |
|||
047-32 | PHOENIX PEPTIDE | 1 mg | 27 EUR |
Joining Peptide (Rat) |
|||
047-91 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
Growth Hormone-Releasing Peptide-Related Peptide-1 (fGRP-RP-1) (Frog) |
|||
048-80 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
Growth Hormone-Releasing Peptide-Related Peptide-2 (fGRP-RP-2) (Frog) |
|||
048-81 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Growth Hormone-Releasing Peptide-Related Peptide-3 (fGRP-RP-3) (Frog) |
|||
048-82 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Peptide T (4-8) |
|||
057-04 | PHOENIX PEPTIDE | 500 μg | 64.8 EUR |
Peptide T (5-8) |
|||
057-05 | PHOENIX PEPTIDE | 500 μg | 64.8 EUR |
Vasonatrin Peptide (VNP) |
|||
005-47 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Opioid Peptide Library |
|||
L-002 | PHOENIX PEPTIDE | 58 peptides | 2691.36 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) |
|||
064-01 | PHOENIX PEPTIDE | 200 μg | 108 EUR |
PGMtide Control Peptide |
|||
040-70 | PHOENIX PEPTIDE | 100 μg | 316.44 EUR |
Growth Blocking Peptide |
|||
046-92 | PHOENIX PEPTIDE | 100 μg | 255.96 EUR |
Neuron Specific Peptide |
|||
047-55 | PHOENIX PEPTIDE | 200 μg | 140.4 EUR |
Heparin Binding Peptide |
|||
025-47 | PHOENIX PEPTIDE | 500 μg | 102.6 EUR |
Gastrin Related Peptide |
|||
027-09 | PHOENIX PEPTIDE | 5 mg | 73.44 EUR |
Obesity Peptide Library |
|||
L-003 | PHOENIX PEPTIDE | 160 peptides | 7267.32 EUR |
[D-Ala1]-Peptide T |
|||
057-02 | PHOENIX PEPTIDE | 5 mg | 282.96 EUR |
Peptide YY (PYY) (Human) |
|||
059-01 | PHOENIX PEPTIDE | 200 μg | 119.88 EUR |
Eledoisin Related Peptide |
|||
046-04 | PHOENIX PEPTIDE | 5 mg | 58.32 EUR |
proSex peptide (28-55) - EIA Kit |
|||
EK-040-31 | PHOENIX PEPTIDE | 96 wells | 603.72 EUR |
Peptide F 1 (Lobster) |
|||
047-62 | PHOENIX PEPTIDE | 500 μg | 73.44 EUR |
Morphine Tolerance Peptide |
|||
050-13 | PHOENIX PEPTIDE | 1 mg | 102.6 EUR |
Phosphate Acceptor Peptide |
|||
058-24 | PHOENIX PEPTIDE | 500 μg | 73.44 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) |
|||
064-07 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia brasiliana) |
|||
047-39 | PHOENIX PEPTIDE | 200 μg | 444.96 EUR |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia brasiliana) |
|||
047-40 | PHOENIX PEPTIDE | 500 μg | 214.92 EUR |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia californica) |
|||
047-42 | PHOENIX PEPTIDE | 200 μg | 444.96 EUR |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia californica) |
|||
047-43 | PHOENIX PEPTIDE | 500 μg | 214.92 EUR |
FGL Peptide - FAM Labeled |
|||
FG-073-36A | PHOENIX PEPTIDE | 1 nmol | 405 EUR |
FGL Peptide - Cy3 Labeled |
|||
FC3-073-36 | PHOENIX PEPTIDE | 1 nmol | 672.84 EUR |
FGL Peptide - Cy5 Labeled |
|||
FC5-073-36 | PHOENIX PEPTIDE | 1 nmol | 756 EUR |
Pedal Peptide (Pep) (Aplysia) |
|||
047-61 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
ExE peptide M3mP6 mutant |
|||
064-35 | PHOENIX PEPTIDE | 200ug | 234.36 EUR |
ExE peptide M3mP6 mutant |
|||
064-37 | PHOENIX PEPTIDE | 200ug | 234.36 EUR |
FGL Peptide - FITC Labeled |
|||
FG-073-36B | PHOENIX PEPTIDE | 1 nmol | 405 EUR |
AF-16 Peptide - Antibody |
|||
H-033-44 | PHOENIX PEPTIDE | 100 μl | 336.96 EUR |
Schizophrenia Related Peptide |
|||
047-79 | PHOENIX PEPTIDE | 5 mg | 44.28 EUR |
Insulin B (22-25) Peptide |
|||
035-08 | PHOENIX PEPTIDE | 5 mg | 86.4 EUR |
Eosinophilotactic Peptide (AGSE) |
|||
070-28 | PHOENIX PEPTIDE | 5 mg | 27 EUR |
Eosinophilotactic Peptide (VGSE) |
|||
070-29 | PHOENIX PEPTIDE | 5 mg | 27 EUR |
Cell Penetrating ARF Peptide (26-44) |
|||
068-56 | PHOENIX PEPTIDE | 500 μg | 640.44 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - RIA Kit |
|||
RK-064-01 | PHOENIX PEPTIDE | 125 tubes | 932.04 EUR |
FGL Peptide - Biotin Labeled |
|||
B-073-36 | PHOENIX PEPTIDE | 20 μg | 405 EUR |
Peptide F (Bovine) - Antibody |
|||
H-024-58 | PHOENIX PEPTIDE | 50 μl | 238.68 EUR |
Brain Peptide (Bees) Library |
|||
L-007 | PHOENIX PEPTIDE | 51 peptides | 6456.24 EUR |
Gastrointestinal Peptide Library |
|||
L-006 | PHOENIX PEPTIDE | 200 peptides | 7267.32 EUR |
Peptide R / CXCR4 Antagonist |
|||
030-25 | PHOENIX PEPTIDE | 200 μg | 203.04 EUR |
PGMtide Peptide - FAM Labeled |
|||
FG-040-69A | PHOENIX PEPTIDE | 5 nmol | 537.84 EUR |
PGMtide Peptide - Cy3 Labeled |
|||
FC3-040-69 | PHOENIX PEPTIDE | 1 nmol | 925.56 EUR |
[D-Arg14, D-Arg15]-MGF Peptide amide / C-terminal peptide of IGF-1 Ec amide |
|||
033-34 | PHOENIX PEPTIDE | 100 μg | 177.12 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Antibody |
|||
H-064-07 | PHOENIX PEPTIDE | 50 μl | 238.68 EUR |
[D-Ala1]-Peptide T amide |
|||
057-03 | PHOENIX PEPTIDE | 500 μg | 140.4 EUR |
Peptide F (Bovine) - RIA Kit |
|||
RK-024-58 | PHOENIX PEPTIDE | 125 tubes | 932.04 EUR |
Calmodulin Binding Peptide 1 |
|||
070-17 | PHOENIX PEPTIDE | 20 μg | 214.92 EUR |
Catch-Relaxing Peptide (CARP) |
|||
047-20 | PHOENIX PEPTIDE | 1 mg | 199.8 EUR |
FGL Peptide - Rhodamine Labeled |
|||
FR-073-36 | PHOENIX PEPTIDE | 1 nmol | 537.84 EUR |
Peptide-Depleted Plasma (Rat) |
|||
MB-099-02 | PHOENIX PEPTIDE | 2 ml | 119.88 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - RIA Kit |
|||
RK-064-07 | PHOENIX PEPTIDE | 125 tubes | 932.04 EUR |
Glycogenolysis-Inhibiting Peptide |
|||
023-63 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
Anti-Inflammatory Peptide 1 |
|||
004-01 | PHOENIX PEPTIDE | 200 μg | 27 EUR |
Anti-Inflammatory Peptide 2 |
|||
004-02 | PHOENIX PEPTIDE | 200 μg | 27 EUR |
Anti-Inflammatory Peptide 3 |
|||
004-03 | PHOENIX PEPTIDE | 200 μg | 27 EUR |
Urokinase-Derived Peptide A6 |
|||
025-12 | PHOENIX PEPTIDE | 500 μg | 129.6 EUR |
PGMtide Peptide - Biotin Labeled |
|||
B-040-69 | PHOENIX PEPTIDE | 20 μg | 537.84 EUR |
Peptide 34 / GPR-54 Agonist |
|||
048-94 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
FGL Peptide - I-125 Labeled |
|||
T-073-36 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Peptide-Depleted Plasma (Human) |
|||
MB-099-01 | PHOENIX PEPTIDE | 2 ml | 119.88 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - FAM Labeled |
|||
FG-064-07A | PHOENIX PEPTIDE | 1 nmol | 336.96 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - I-125 Labeled |
|||
T-064-01 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
F3 Peptide / HMGN2 Fragment 3 |
|||
004-12 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Antimicrobial Trp-rich peptide |
|||
004-05 | PHOENIX PEPTIDE | 100 μg | 140.4 EUR |
Myosin Kinase Inhibiting Peptide |
|||
058-20 | PHOENIX PEPTIDE | 500 μg | 50.76 EUR |
Fibronectin CS1 Peptide (EILDVPST) |
|||
025-20 | PHOENIX PEPTIDE | 500 μg | 86.4 EUR |
Peptide YY (PYY) (3-36) (Human) |
|||
059-02 | PHOENIX PEPTIDE | 200 μg | 102.6 EUR |
Peptide YY (PYY) (Human) - Antibody |
|||
H-059-01 | PHOENIX PEPTIDE | 100 μl | 469.8 EUR |
PGMtide Peptide - Rhodamine Labeled |
|||
FR-040-69 | PHOENIX PEPTIDE | 5 nmol | 604.8 EUR |
Anti-Angiogenic Peptide Library |
|||
L-008A | PHOENIX PEPTIDE | 88 peptides | 6067.44 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - Purified IgG Antibody |
|||
G-064-01 | PHOENIX PEPTIDE | 400 μg | 438.48 EUR |
Peptide A / p60v-src (137-157) |
|||
058-21 | PHOENIX PEPTIDE | 500 μg | 135 EUR |
pro-Opionmelanocortin / J Peptide |
|||
022-22 | PHOENIX PEPTIDE | 200 μg | 177.12 EUR |
Cancer-Targeting Peptide Library |
|||
L-015 | PHOENIX PEPTIDE | 289 peptides | 7253.28 EUR |
C28 optimized peptide 6 (Human) |
|||
073-82 | PHOENIX PEPTIDE | 100 μg | 235.44 EUR |
Peptide YY (PYY) (Human) - EIA Kit |
|||
EK-059-01 | PHOENIX PEPTIDE | 96 wells | 617.76 EUR |
Peptide YY (PYY) (Human) - RIA Kit |
|||
RK-059-01 | PHOENIX PEPTIDE | 125 tubes | 814.32 EUR |
Kemptide / Phosphate Acceptor Peptide |
|||
058-16 | PHOENIX PEPTIDE | 500 μg | 36.72 EUR |
Bioactive Secretory Peptide Library |
|||
L-009 | PHOENIX PEPTIDE | 1016 peptides | 31350.24 EUR |
PACAP-Related Peptide (PRP) (Rat) |
|||
052-11 | PHOENIX PEPTIDE | 200 μg | 86.4 EUR |
Galanin-Like Peptide (GALP) (Rat) |
|||
026-52 | PHOENIX PEPTIDE | 100 μg | 282.96 EUR |
DISP3 Peptide |
|||
4893P | ProSci | 0.05 mg | 197.7 EUR |
Description: (NT) DISP2 peptide |
|||
DISP1 Peptide |
|||
6629P | ProSci | 0.05 mg | 197.7 EUR |
Description: (NT) DISP1 peptide |
|||
DISP3 Peptide |
|||
MBS153195-005mg | MyBiosource | 0.05mg | 175 EUR |
DISP3 Peptide |
|||
MBS153195-5x005mg | MyBiosource | 5x0.05mg | 770 EUR |
DISP1 Peptide |
|||
MBS153278-005mg | MyBiosource | 0.05mg | 175 EUR |
DISP1 Peptide |
|||
MBS153278-5x005mg | MyBiosource | 5x0.05mg | 770 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - I-125 Labeled |
|||
T-064-07 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Virus Replication Inhibiting Peptide |
|||
070-85 | PHOENIX PEPTIDE | 5 mg | 160.92 EUR |
Crustacean Cardioactive Peptide (CCAP) |
|||
047-24 | PHOENIX PEPTIDE | 500 μg | 86.4 EUR |
Pri Peptide from sORF pri RNA |
|||
069-77 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
Alzheimer Fingerprint Peptide Library |
|||
L-011 | PHOENIX PEPTIDE | 85 peptides | 6529.68 EUR |
u PAR (84-95) Scrambled Peptide |
|||
072-47 | PHOENIX PEPTIDE | 200 μg | 177.12 EUR |
PACAP-Related Peptide (PRP) (Human) |
|||
052-10 | PHOENIX PEPTIDE | 200 μg | 86.4 EUR |
Scrambled Control for Pri Peptide |
|||
069-78 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
FMRF-Like Peptide (Helix aspersa) |
|||
047-31 | PHOENIX PEPTIDE | 1 mg | 27 EUR |
Annexin A1 Binding Peptide, IF7CRR |
|||
025-72 | PHOENIX PEPTIDE | 200 μg | 184.68 EUR |
Galanin-Like Peptide (GALP) (Human) |
|||
026-51 | PHOENIX PEPTIDE | 100 μg | 230.04 EUR |
Gastrin Releasing Peptide (GRP) (Rat) |
|||
027-32 | PHOENIX PEPTIDE | 100 μg | 160.92 EUR |
Kinetensin / Neurotensin Related Peptide |
|||
048-01 | PHOENIX PEPTIDE | 500 μg | 58.32 EUR |
Small Cardioactive Peptide A (SCPA) |
|||
047-76 | PHOENIX PEPTIDE | 1 mg | 64.8 EUR |
Gastrin Releasing Peptide (GRP) (Frog) |
|||
027-33 | PHOENIX PEPTIDE | 100 μg | 160.92 EUR |
Epidermal Growth Factor Receptor Peptide (985-996) |
|||
030-05 | PHOENIX PEPTIDE | 500 μg | 102.6 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Purified IgG Antibody |
|||
G-064-07 | PHOENIX PEPTIDE | 400 μg | 438.48 EUR |
Galanin-Like Peptide (GALP) (Porcine) |
|||
026-50 | PHOENIX PEPTIDE | 100 μg | 230.04 EUR |
Gastrin Releasing Peptide (GRP) (Human) |
|||
027-07 | PHOENIX PEPTIDE | 200 μg | 119.88 EUR |
Gastrin Releasing Peptide (GRP) (Mouse) |
|||
027-40 | PHOENIX PEPTIDE | 100 μg | 160.92 EUR |
PGMtide Control Peptide - FAM Labeled |
|||
FG-040-70A | PHOENIX PEPTIDE | 5 nmol | 537.84 EUR |
Growth Blocking Peptide - FAM Labeled |
|||
FG-046-92A | PHOENIX PEPTIDE | 1 nmol | 336.96 EUR |
PGMtide Control Peptide - Cy3 Labeled |
|||
FC3-040-70 | PHOENIX PEPTIDE | 1 nmol | 925.56 EUR |
Chop-Suey / Variety Peptide Library |
|||
L-001 | PHOENIX PEPTIDE | 238 peptides | 7400.16 EUR |
T3 Peptide / Tumstatin (69-88) (Human) |
|||
016-50 | PHOENIX PEPTIDE | 100 μg | 255.96 EUR |
T7 Peptide / Tumstatin (74-98) (Human) |
|||
016-51 | PHOENIX PEPTIDE | 100 μg | 255.96 EUR |
Peptide YY (PYY) (1-36)-Gly (Human) |
|||
059-07 | PHOENIX PEPTIDE | 100 μg | 295.92 EUR |
Peptide YY (PYY) (3-36)-Gly (Human) |
|||
059-08 | PHOENIX PEPTIDE | 100 μg | 282.96 EUR |
Peptide YY (PYY) (2-36)-Gly (Human) |
|||
059-11 | PHOENIX PEPTIDE | 100 μg | 267.84 EUR |
Peptide YY (PYY) (4-36)-Gly (Human) |
|||
059-12 | PHOENIX PEPTIDE | 100 μg | 267.84 EUR |
Hypocholesterolemic Peptide / IIAEK (Bovine) |
|||
028-37 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
Fractalkine Chemokine Domain peptide (41-52) (Human) |
|||
026-82 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
Fractalkine Chemokine Domain peptide (53-60) (Human) |
|||
026-83 | PHOENIX PEPTIDE | 200 μg | 135 EUR |
Fractalkine Chemokine Domain peptide (60-71) (Human) |
|||
026-84 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
FMRF-Like Peptide ( Lymnae stagnalis) |
|||
047-30 | PHOENIX PEPTIDE | 5 mg | 129.6 EUR |
Peptide F (Bovine) - I-125 Labeled |
|||
T-024-58 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Kappa-Receptor, C-terminal peptide |
|||
002-98 | PHOENIX PEPTIDE | 100 μg | 469.8 EUR |
Angiotensin II - constrained peptide 1 |
|||
004-09 | PHOENIX PEPTIDE | 500 μg | 165.24 EUR |
VEGFR binding peptide KH / QKRKRKKSRKKH |
|||
007-58 | PHOENIX PEPTIDE | 100 μg | 158.76 EUR |
Delta-Sleep-Inducing Peptide (DSIP) |
|||
070-22 | PHOENIX PEPTIDE | 500 μg | 27 EUR |
[Thr5]-Speract / Sperm Activating Peptide |
|||
070-71 | PHOENIX PEPTIDE | 1 mg | 114.48 EUR |
Stresscopin Related Peptide (SRP) (Human) |
|||
019-27 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Gastrin Releasing Peptide (GRP) (Porcine) |
|||
027-13 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
[D-Ala1]-Peptide T - Biotin Labeled |
|||
B-057-02 | PHOENIX PEPTIDE | 100 μg | 316.44 EUR |
F3 Peptide (4-13) / HMGN2 Fragment 3 (4-13) |
|||
004-13 | PHOENIX PEPTIDE | 200 μg | 177.12 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - I-125 Labeled Purified IgG |
|||
T-G-064-01 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
PGMtide Control Peptide - Biotin Labeled |
|||
B-040-70 | PHOENIX PEPTIDE | 20 μg | 537.84 EUR |
Growth Blocking Peptide - Biotin Labeled |
|||
B-046-92 | PHOENIX PEPTIDE | 20 μg | 336.96 EUR |
Orphan Receptor Peptide Ligand Library |
|||
L-005 | PHOENIX PEPTIDE | 150 peptides | 7938 EUR |
Nesfatin-1-Like Peptide (NLP) (Rat) |
|||
009-85 | PHOENIX PEPTIDE | 100 μg | 461.16 EUR |
SHAAG Peptide / Chemokine (46-63) (Human) |
|||
072-32 | PHOENIX PEPTIDE | 100 μg | 160.92 EUR |
C28 optimized peptide 15 Dimer (Human) |
|||
073-86 | PHOENIX PEPTIDE | 100 μg | 420.12 EUR |
Prolactin-Releasing Peptide-31 (PrRP-31) (Rat) |
|||
008-52 | PHOENIX PEPTIDE | 200 μg | 199.8 EUR |
Prolactin-Releasing Peptide-20 (PrRP-20) (Rat) |
|||
008-53 | PHOENIX PEPTIDE | 200 μg | 199.8 EUR |
Osteoblast Activating Peptide (OBAP) (Human) |
|||
055-52 | PHOENIX PEPTIDE | 100 μg | 199.8 EUR |
Analysis of an Amino Acid Combine on the Secretion of Gastrointestinal Peptides, Glucometabolic Homeostasis, and Urge for food in Overweight Adolescents Administered with a Fastened-Dose or advert Libitum Meal
Proteins have been demonstrated to cut back meals consumption in animals and people through peripheral and central mechanisms. Supplementation of a dietetic routine with single or blended amino acids may symbolize an method to enhance the effectiveness of any physique weight discount program in overweight topics.
The intention of the current research was to judge the consequences of an amino acid combine (L-arginine + L-leucine + L-glutamine + L-tryptophan) on the secretion of some gastrointestinal peptides (i.e., ghrelin and glucagon-like peptide sort 1, GLP-1), glucometabolic homeostasis (i.e., glucose, insulin, and glucagon), and urge for food (starvation/satiety scored by visible analogue scale, VAS) in overweight adolescents (n = 14; 10 females and Four males; age: 16.6 ± 1.zero years; physique mass index (BMI): 36.4 ± 4.6 kg/m²; fat-free mass (FFM): 54.9 ± 4.7%; fats mass (FM): 45.1 ± 4.4%) administered with a fixed-dose (lunch) or advert libitum (dinner) meal.
Isocaloric maltodextrins have been used as management remedy. In the course of the lunch check, a major improve in circulating ranges of GLP-1, however not of ghrelin, was noticed within the amino acid-treated group, which was congruent with vital adjustments in urge for food, i.e., improve in satiety and reduce in starvation.
A big hyperglycemia was discovered within the maltodextrin-treated group throughout the prelunch interval, with none vital adjustments in insulin and glucagon between the 2 teams. In the course of the dinner check, there have been no vital variations in urge for food (starvation/satiety) and consumption of energy.
In conclusion, L-arginine, L-leucine, L-glutamine, and L-tryptophan, when administered to overweight adolescents with a fixed-dose meal, are able to evoking an anorexigenic response, which is, at the very least partially, mediated by a rise in GLP-1 launched in circulation by L cells, that are able to chemosensing particular amino acids current within the intestinal lumen. Additional extra research are requested to grasp whether or not increased doses are essential to inhibit advert libitum feeding.
Auto-reactivity towards intestine bacterial peptides in sufferers with late-onset diabetes
The depletion of intestine mucosal barrier allows publicity of intestine microbes/intestine microbial merchandise to the host mucosal immunity which can improve the danger of metabolic/inflammatory problems. These immune responses can result in the event of delicate autoimmunity to metabolic peptides coming from intestine micro organism and should end in metabolic ailments like late-onset diabetes (LOD).
Within the current research, we recognized host sera cross-reactivity with intestine bacterial peptides just like host proteins. The interplay between diabetic sera and intestine peptides was detected by enzyme-linked immunosorbent assay (ELISA) and outcomes have been confirmed utilizing floor plasmon resonance (SPR). The ELISA assay confirmed the next stage of serum cross-reactivity in LOD sufferers as in comparison with non-diabetic controls towards three peptides (P-5, P-9, and P-13). SPR evaluation confirmed binding-affinity towards P-5 and P-13. Additionally, a major correlation was noticed between inflammatory markers and P-5. This research demonstrates that intestine well being is essential not just for intestinal ailments but additionally for a number of late-onset ailments, like, diabetes.
IRF4 Peptide |
|||
MBS3228900-01mg | MyBiosource | 0.1mg | 180 EUR |
IRF4 Peptide |
|||
MBS3228900-5x01mg | MyBiosource | 5x0.1mg | 730 EUR |
IRF4 Blocking Peptide |
|||
DF6198-BP | Affbiotech | 1mg | 234 EUR |
IRF4 Blocking Peptide |
|||
20-abx062142 | Abbexa |
|
|
IRF4 Blocking Peptide |
|||
AF0692-BP | Affbiotech | 1mg | 234 EUR |
IRF4 Blocking Peptide |
|||
AF4776-BP | Affbiotech | 1mg | 234 EUR |
IRF4 Blocking Peptide |
|||
MBS428901-01mg | MyBiosource | 0.1mg | 230 EUR |
IRF4 Blocking Peptide |
|||
MBS8209654-1mg | MyBiosource | 1mg | 190 EUR |
IRF4 Blocking Peptide |
|||
MBS8209654-5mg | MyBiosource | 5mg | 345 EUR |
IRF4 Blocking Peptide |
|||
MBS8209654-5x5mg | MyBiosource | 5x5mg | 1465 EUR |
IRF4 Blocking Peptide |
|||
MBS9625574-1mg | MyBiosource | 1mg | 380 EUR |
IRF4 Blocking Peptide |
|||
MBS9625574-5x1mg | MyBiosource | 5x1mg | 1650 EUR |
IRF4 Blocking Peptide |
|||
MBS9615069-1mg | MyBiosource | 1mg | 380 EUR |
IRF4 Blocking Peptide |
|||
MBS9615069-5x1mg | MyBiosource | 5x1mg | 1650 EUR |
IRF4 Blocking Peptide |
|||
MBS9616765-1mg | MyBiosource | 1mg | 380 EUR |
IRF4 Blocking Peptide |
|||
MBS9616765-5x1mg | MyBiosource | 5x1mg | 1650 EUR |
IRF4 Immunizing Peptide |
|||
MBS427645-01mg | MyBiosource | 0.1mg | 225 EUR |
IRF4 Peptide - middle region |
|||
MBS3228901-01mg | MyBiosource | 0.1mg | 180 EUR |
IRF4 Peptide - middle region |
|||
MBS3228901-5x01mg | MyBiosource | 5x0.1mg | 730 EUR |
AAP38154-100UG - IRF4 Peptide |
|||
AAP38154-100UG | Aviva Systems Biology | 100ug | 99 EUR |
AAP32669-100UG - IRF4 Peptide |
|||
AAP32669-100UG | Aviva Systems Biology | 100ug | 99 EUR |
IRF4 Peptide - N-terminal region |
|||
MBS3248213-01mg | MyBiosource | 0.1mg | 180 EUR |
IRF4 Peptide - N-terminal region |
|||
MBS3248213-5x01mg | MyBiosource | 5x0.1mg | 730 EUR |
Mast Cell-Degranulating Peptide (MCD Peptide) / Peptide 401 |
|||
004-04 | PHOENIX PEPTIDE | 100 μg | 140.4 EUR |
IRF4 Antibody (Center) Blocking peptide |
|||
MBS9219288-INQUIRE | MyBiosource | INQUIRE | Ask for price |
AAP38155-100UG - IRF4 Peptide - middle region |
|||
AAP38155-100UG | Aviva Systems Biology | 100ug | 99 EUR |
Peptide T |
|||
057-01 | PHOENIX PEPTIDE | 5 mg | 140.4 EUR |
FGL Peptide |
|||
073-36 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
APK peptide |
|||
076-81 | PHOENIX PEPTIDE | 200 μg | 199.8 EUR |
NEF peptide |
|||
076-83 | PHOENIX PEPTIDE | 500 μg | 140.4 EUR |
SHA peptide |
|||
076-84 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
YSY peptide |
|||
076-86 | PHOENIX PEPTIDE | 100 μg | 230.04 EUR |
Peptide E / 3200-Dalton Adrenal Enkephalin-Containing Peptide (Bovine) |
|||
024-57 | PHOENIX PEPTIDE | 200 μg | 86.4 EUR |
PSTAIR Peptide |
|||
070-61 | PHOENIX PEPTIDE | 500 μg | 129.6 EUR |
PGMtide Peptide |
|||
040-69 | PHOENIX PEPTIDE | 100 μg | 316.44 EUR |
Adjuvant Peptide |
|||
070-05 | PHOENIX PEPTIDE | 500 μg | 36.72 EUR |
Peptide-epsilon |
|||
058-22 | PHOENIX PEPTIDE | 500 μg | 114.48 EUR |
Delicious Peptide |
|||
070-21 | PHOENIX PEPTIDE | 5 mg | 160.92 EUR |
proSex peptide (20-55) |
|||
040-30 | PHOENIX PEPTIDE | 100 μg | 355.32 EUR |
proSex peptide (28-55) |
|||
040-31 | PHOENIX PEPTIDE | 100 μg | 282.96 EUR |
proSex peptide (40-55) |
|||
040-32 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Bombinin-Like Peptide 1 amide / prepro-Bombinin-Like Peptide (44-70) amide / prepro-Bombinin-Like Peptide (107-133) amide |
|||
007-60 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Peptide F-9 |
|||
038-06 | PHOENIX PEPTIDE | 200 μg | 58.32 EUR |
Sturgeon Peptide (137-158) |
|||
021-94 | PHOENIX PEPTIDE | 100 μg | 177.12 EUR |
Peptide Lv (Rat) |
|||
008-73 | PHOENIX PEPTIDE | 100 μg | 469.8 EUR |
NGR Peptide 1 |
|||
025-74 | PHOENIX PEPTIDE | 200 μg | 184.68 EUR |
Anorexigenic Peptide |
|||
070-10 | PHOENIX PEPTIDE | 5 mg | 86.4 EUR |
GnRH Associated Peptide (GAP) (1-13) / GnRH Precursor Peptide (14-26) (Human) |
|||
029-03 | PHOENIX PEPTIDE | 500 μg | 114.48 EUR |
GnRH Associated Peptide (GAP) (1-24) / GnRH Precursor Peptide (14-37) (Human) |
|||
029-04 | PHOENIX PEPTIDE | 100 μg | 114.48 EUR |
GnRH Associated Peptide (GAP) (1-53) / GnRH Precursor Peptide (14-66) (Human) |
|||
029-05 | PHOENIX PEPTIDE | 20 μg | 267.84 EUR |
GnRH Associated Peptide (GAP) (25-53) / GnRH Precursor Peptide (38-66) (Human) |
|||
029-06 | PHOENIX PEPTIDE | 100 μg | 114.48 EUR |
Bid BH3 peptide |
|||
025-87 | PHOENIX PEPTIDE | 1 mg | 170.64 EUR |
AF-16 Peptide |
|||
033-44 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Peptide Lv (Human) |
|||
008-71 | PHOENIX PEPTIDE | 100 μg | 405 EUR |
Peptide Lv (Mouse) |
|||
008-72 | PHOENIX PEPTIDE | 100 μg | 469.8 EUR |
GnRH Associated Peptide (GAP) (1-13) / Gn-RH Precursor Peptide (14-26) (Rat) |
|||
029-08 | PHOENIX PEPTIDE | 200 μg | 64.8 EUR |
ExE peptide M3mP6 |
|||
064-33 | PHOENIX PEPTIDE | 200 μg | 244.08 EUR |
Peptide B (Bovine) |
|||
024-56 | PHOENIX PEPTIDE | 200 μg | 81 EUR |
Peptide F (Bovine) |
|||
024-58 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
PLP Peptide (103-116) (Bovine) |
|||
070-14 | PHOENIX PEPTIDE | 5 mg | 140.4 EUR |
FMRF-Like Peptide |
|||
047-32 | PHOENIX PEPTIDE | 1 mg | 27 EUR |
Joining Peptide (Rat) |
|||
047-91 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
Growth Hormone-Releasing Peptide-Related Peptide-1 (fGRP-RP-1) (Frog) |
|||
048-80 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
Growth Hormone-Releasing Peptide-Related Peptide-2 (fGRP-RP-2) (Frog) |
|||
048-81 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Growth Hormone-Releasing Peptide-Related Peptide-3 (fGRP-RP-3) (Frog) |
|||
048-82 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Peptide T (4-8) |
|||
057-04 | PHOENIX PEPTIDE | 500 μg | 64.8 EUR |
Peptide T (5-8) |
|||
057-05 | PHOENIX PEPTIDE | 500 μg | 64.8 EUR |
Vasonatrin Peptide (VNP) |
|||
005-47 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Opioid Peptide Library |
|||
L-002 | PHOENIX PEPTIDE | 58 peptides | 2691.36 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) |
|||
064-01 | PHOENIX PEPTIDE | 200 μg | 108 EUR |
PGMtide Control Peptide |
|||
040-70 | PHOENIX PEPTIDE | 100 μg | 316.44 EUR |
Growth Blocking Peptide |
|||
046-92 | PHOENIX PEPTIDE | 100 μg | 255.96 EUR |
Neuron Specific Peptide |
|||
047-55 | PHOENIX PEPTIDE | 200 μg | 140.4 EUR |
Heparin Binding Peptide |
|||
025-47 | PHOENIX PEPTIDE | 500 μg | 102.6 EUR |
Gastrin Related Peptide |
|||
027-09 | PHOENIX PEPTIDE | 5 mg | 73.44 EUR |
Obesity Peptide Library |
|||
L-003 | PHOENIX PEPTIDE | 160 peptides | 7267.32 EUR |
[D-Ala1]-Peptide T |
|||
057-02 | PHOENIX PEPTIDE | 5 mg | 282.96 EUR |
Peptide YY (PYY) (Human) |
|||
059-01 | PHOENIX PEPTIDE | 200 μg | 119.88 EUR |
Eledoisin Related Peptide |
|||
046-04 | PHOENIX PEPTIDE | 5 mg | 58.32 EUR |
proSex peptide (28-55) - EIA Kit |
|||
EK-040-31 | PHOENIX PEPTIDE | 96 wells | 603.72 EUR |
Peptide F 1 (Lobster) |
|||
047-62 | PHOENIX PEPTIDE | 500 μg | 73.44 EUR |
Morphine Tolerance Peptide |
|||
050-13 | PHOENIX PEPTIDE | 1 mg | 102.6 EUR |
Phosphate Acceptor Peptide |
|||
058-24 | PHOENIX PEPTIDE | 500 μg | 73.44 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) |
|||
064-07 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia brasiliana) |
|||
047-39 | PHOENIX PEPTIDE | 200 μg | 444.96 EUR |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia brasiliana) |
|||
047-40 | PHOENIX PEPTIDE | 500 μg | 214.92 EUR |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia californica) |
|||
047-42 | PHOENIX PEPTIDE | 200 μg | 444.96 EUR |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia californica) |
|||
047-43 | PHOENIX PEPTIDE | 500 μg | 214.92 EUR |
FGL Peptide - FAM Labeled |
|||
FG-073-36A | PHOENIX PEPTIDE | 1 nmol | 405 EUR |
FGL Peptide - Cy3 Labeled |
|||
FC3-073-36 | PHOENIX PEPTIDE | 1 nmol | 672.84 EUR |
FGL Peptide - Cy5 Labeled |
|||
FC5-073-36 | PHOENIX PEPTIDE | 1 nmol | 756 EUR |
Pedal Peptide (Pep) (Aplysia) |
|||
047-61 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
ExE peptide M3mP6 mutant |
|||
064-35 | PHOENIX PEPTIDE | 200ug | 234.36 EUR |
ExE peptide M3mP6 mutant |
|||
064-37 | PHOENIX PEPTIDE | 200ug | 234.36 EUR |
FGL Peptide - FITC Labeled |
|||
FG-073-36B | PHOENIX PEPTIDE | 1 nmol | 405 EUR |
AF-16 Peptide - Antibody |
|||
H-033-44 | PHOENIX PEPTIDE | 100 μl | 336.96 EUR |
Schizophrenia Related Peptide |
|||
047-79 | PHOENIX PEPTIDE | 5 mg | 44.28 EUR |
Insulin B (22-25) Peptide |
|||
035-08 | PHOENIX PEPTIDE | 5 mg | 86.4 EUR |
Eosinophilotactic Peptide (AGSE) |
|||
070-28 | PHOENIX PEPTIDE | 5 mg | 27 EUR |
Eosinophilotactic Peptide (VGSE) |
|||
070-29 | PHOENIX PEPTIDE | 5 mg | 27 EUR |
Cell Penetrating ARF Peptide (26-44) |
|||
068-56 | PHOENIX PEPTIDE | 500 μg | 640.44 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - RIA Kit |
|||
RK-064-01 | PHOENIX PEPTIDE | 125 tubes | 932.04 EUR |
FGL Peptide - Biotin Labeled |
|||
B-073-36 | PHOENIX PEPTIDE | 20 μg | 405 EUR |
Peptide F (Bovine) - Antibody |
|||
H-024-58 | PHOENIX PEPTIDE | 50 μl | 238.68 EUR |
Brain Peptide (Bees) Library |
|||
L-007 | PHOENIX PEPTIDE | 51 peptides | 6456.24 EUR |
Gastrointestinal Peptide Library |
|||
L-006 | PHOENIX PEPTIDE | 200 peptides | 7267.32 EUR |
Peptide R / CXCR4 Antagonist |
|||
030-25 | PHOENIX PEPTIDE | 200 μg | 203.04 EUR |
PGMtide Peptide - FAM Labeled |
|||
FG-040-69A | PHOENIX PEPTIDE | 5 nmol | 537.84 EUR |
PGMtide Peptide - Cy3 Labeled |
|||
FC3-040-69 | PHOENIX PEPTIDE | 1 nmol | 925.56 EUR |
[D-Arg14, D-Arg15]-MGF Peptide amide / C-terminal peptide of IGF-1 Ec amide |
|||
033-34 | PHOENIX PEPTIDE | 100 μg | 177.12 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Antibody |
|||
H-064-07 | PHOENIX PEPTIDE | 50 μl | 238.68 EUR |
[D-Ala1]-Peptide T amide |
|||
057-03 | PHOENIX PEPTIDE | 500 μg | 140.4 EUR |
Peptide F (Bovine) - RIA Kit |
|||
RK-024-58 | PHOENIX PEPTIDE | 125 tubes | 932.04 EUR |
Calmodulin Binding Peptide 1 |
|||
070-17 | PHOENIX PEPTIDE | 20 μg | 214.92 EUR |
Catch-Relaxing Peptide (CARP) |
|||
047-20 | PHOENIX PEPTIDE | 1 mg | 199.8 EUR |
FGL Peptide - Rhodamine Labeled |
|||
FR-073-36 | PHOENIX PEPTIDE | 1 nmol | 537.84 EUR |
Peptide-Depleted Plasma (Rat) |
|||
MB-099-02 | PHOENIX PEPTIDE | 2 ml | 119.88 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - RIA Kit |
|||
RK-064-07 | PHOENIX PEPTIDE | 125 tubes | 932.04 EUR |
Glycogenolysis-Inhibiting Peptide |
|||
023-63 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
Anti-Inflammatory Peptide 1 |
|||
004-01 | PHOENIX PEPTIDE | 200 μg | 27 EUR |
Anti-Inflammatory Peptide 2 |
|||
004-02 | PHOENIX PEPTIDE | 200 μg | 27 EUR |
Anti-Inflammatory Peptide 3 |
|||
004-03 | PHOENIX PEPTIDE | 200 μg | 27 EUR |
Urokinase-Derived Peptide A6 |
|||
025-12 | PHOENIX PEPTIDE | 500 μg | 129.6 EUR |
PGMtide Peptide - Biotin Labeled |
|||
B-040-69 | PHOENIX PEPTIDE | 20 μg | 537.84 EUR |
Peptide 34 / GPR-54 Agonist |
|||
048-94 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
FGL Peptide - I-125 Labeled |
|||
T-073-36 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Peptide-Depleted Plasma (Human) |
|||
MB-099-01 | PHOENIX PEPTIDE | 2 ml | 119.88 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - FAM Labeled |
|||
FG-064-07A | PHOENIX PEPTIDE | 1 nmol | 336.96 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - I-125 Labeled |
|||
T-064-01 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
F3 Peptide / HMGN2 Fragment 3 |
|||
004-12 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Antimicrobial Trp-rich peptide |
|||
004-05 | PHOENIX PEPTIDE | 100 μg | 140.4 EUR |
Myosin Kinase Inhibiting Peptide |
|||
058-20 | PHOENIX PEPTIDE | 500 μg | 50.76 EUR |
Fibronectin CS1 Peptide (EILDVPST) |
|||
025-20 | PHOENIX PEPTIDE | 500 μg | 86.4 EUR |
Peptide YY (PYY) (3-36) (Human) |
|||
059-02 | PHOENIX PEPTIDE | 200 μg | 102.6 EUR |
Peptide YY (PYY) (Human) - Antibody |
|||
H-059-01 | PHOENIX PEPTIDE | 100 μl | 469.8 EUR |
PGMtide Peptide - Rhodamine Labeled |
|||
FR-040-69 | PHOENIX PEPTIDE | 5 nmol | 604.8 EUR |
Anti-Angiogenic Peptide Library |
|||
L-008A | PHOENIX PEPTIDE | 88 peptides | 6067.44 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - Purified IgG Antibody |
|||
G-064-01 | PHOENIX PEPTIDE | 400 μg | 438.48 EUR |
Peptide A / p60v-src (137-157) |
|||
058-21 | PHOENIX PEPTIDE | 500 μg | 135 EUR |
pro-Opionmelanocortin / J Peptide |
|||
022-22 | PHOENIX PEPTIDE | 200 μg | 177.12 EUR |
Cancer-Targeting Peptide Library |
|||
L-015 | PHOENIX PEPTIDE | 289 peptides | 7253.28 EUR |
C28 optimized peptide 6 (Human) |
|||
073-82 | PHOENIX PEPTIDE | 100 μg | 235.44 EUR |
Peptide YY (PYY) (Human) - EIA Kit |
|||
EK-059-01 | PHOENIX PEPTIDE | 96 wells | 617.76 EUR |
Peptide YY (PYY) (Human) - RIA Kit |
|||
RK-059-01 | PHOENIX PEPTIDE | 125 tubes | 814.32 EUR |
Kemptide / Phosphate Acceptor Peptide |
|||
058-16 | PHOENIX PEPTIDE | 500 μg | 36.72 EUR |
Bioactive Secretory Peptide Library |
|||
L-009 | PHOENIX PEPTIDE | 1016 peptides | 31350.24 EUR |
PACAP-Related Peptide (PRP) (Rat) |
|||
052-11 | PHOENIX PEPTIDE | 200 μg | 86.4 EUR |
Galanin-Like Peptide (GALP) (Rat) |
|||
026-52 | PHOENIX PEPTIDE | 100 μg | 282.96 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - I-125 Labeled |
|||
T-064-07 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Virus Replication Inhibiting Peptide |
|||
070-85 | PHOENIX PEPTIDE | 5 mg | 160.92 EUR |
Crustacean Cardioactive Peptide (CCAP) |
|||
047-24 | PHOENIX PEPTIDE | 500 μg | 86.4 EUR |
Pri Peptide from sORF pri RNA |
|||
069-77 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
Alzheimer Fingerprint Peptide Library |
|||
L-011 | PHOENIX PEPTIDE | 85 peptides | 6529.68 EUR |
u PAR (84-95) Scrambled Peptide |
|||
072-47 | PHOENIX PEPTIDE | 200 μg | 177.12 EUR |
PACAP-Related Peptide (PRP) (Human) |
|||
052-10 | PHOENIX PEPTIDE | 200 μg | 86.4 EUR |
Scrambled Control for Pri Peptide |
|||
069-78 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
FMRF-Like Peptide (Helix aspersa) |
|||
047-31 | PHOENIX PEPTIDE | 1 mg | 27 EUR |
Annexin A1 Binding Peptide, IF7CRR |
|||
025-72 | PHOENIX PEPTIDE | 200 μg | 184.68 EUR |
Galanin-Like Peptide (GALP) (Human) |
|||
026-51 | PHOENIX PEPTIDE | 100 μg | 230.04 EUR |
Gastrin Releasing Peptide (GRP) (Rat) |
|||
027-32 | PHOENIX PEPTIDE | 100 μg | 160.92 EUR |
Kinetensin / Neurotensin Related Peptide |
|||
048-01 | PHOENIX PEPTIDE | 500 μg | 58.32 EUR |
Small Cardioactive Peptide A (SCPA) |
|||
047-76 | PHOENIX PEPTIDE | 1 mg | 64.8 EUR |
Gastrin Releasing Peptide (GRP) (Frog) |
|||
027-33 | PHOENIX PEPTIDE | 100 μg | 160.92 EUR |
Epidermal Growth Factor Receptor Peptide (985-996) |
|||
030-05 | PHOENIX PEPTIDE | 500 μg | 102.6 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Purified IgG Antibody |
|||
G-064-07 | PHOENIX PEPTIDE | 400 μg | 438.48 EUR |
Galanin-Like Peptide (GALP) (Porcine) |
|||
026-50 | PHOENIX PEPTIDE | 100 μg | 230.04 EUR |
Gastrin Releasing Peptide (GRP) (Human) |
|||
027-07 | PHOENIX PEPTIDE | 200 μg | 119.88 EUR |
Gastrin Releasing Peptide (GRP) (Mouse) |
|||
027-40 | PHOENIX PEPTIDE | 100 μg | 160.92 EUR |
PGMtide Control Peptide - FAM Labeled |
|||
FG-040-70A | PHOENIX PEPTIDE | 5 nmol | 537.84 EUR |
Growth Blocking Peptide - FAM Labeled |
|||
FG-046-92A | PHOENIX PEPTIDE | 1 nmol | 336.96 EUR |
PGMtide Control Peptide - Cy3 Labeled |
|||
FC3-040-70 | PHOENIX PEPTIDE | 1 nmol | 925.56 EUR |
Chop-Suey / Variety Peptide Library |
|||
L-001 | PHOENIX PEPTIDE | 238 peptides | 7400.16 EUR |
T3 Peptide / Tumstatin (69-88) (Human) |
|||
016-50 | PHOENIX PEPTIDE | 100 μg | 255.96 EUR |
T7 Peptide / Tumstatin (74-98) (Human) |
|||
016-51 | PHOENIX PEPTIDE | 100 μg | 255.96 EUR |
Peptide YY (PYY) (1-36)-Gly (Human) |
|||
059-07 | PHOENIX PEPTIDE | 100 μg | 295.92 EUR |
Peptide YY (PYY) (3-36)-Gly (Human) |
|||
059-08 | PHOENIX PEPTIDE | 100 μg | 282.96 EUR |
Peptide YY (PYY) (2-36)-Gly (Human) |
|||
059-11 | PHOENIX PEPTIDE | 100 μg | 267.84 EUR |
Peptide YY (PYY) (4-36)-Gly (Human) |
|||
059-12 | PHOENIX PEPTIDE | 100 μg | 267.84 EUR |
Hypocholesterolemic Peptide / IIAEK (Bovine) |
|||
028-37 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
Fractalkine Chemokine Domain peptide (41-52) (Human) |
|||
026-82 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
Fractalkine Chemokine Domain peptide (53-60) (Human) |
|||
026-83 | PHOENIX PEPTIDE | 200 μg | 135 EUR |
Fractalkine Chemokine Domain peptide (60-71) (Human) |
|||
026-84 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
FMRF-Like Peptide ( Lymnae stagnalis) |
|||
047-30 | PHOENIX PEPTIDE | 5 mg | 129.6 EUR |
Peptide F (Bovine) - I-125 Labeled |
|||
T-024-58 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Kappa-Receptor, C-terminal peptide |
|||
002-98 | PHOENIX PEPTIDE | 100 μg | 469.8 EUR |
Angiotensin II - constrained peptide 1 |
|||
004-09 | PHOENIX PEPTIDE | 500 μg | 165.24 EUR |
VEGFR binding peptide KH / QKRKRKKSRKKH |
|||
007-58 | PHOENIX PEPTIDE | 100 μg | 158.76 EUR |
Delta-Sleep-Inducing Peptide (DSIP) |
|||
070-22 | PHOENIX PEPTIDE | 500 μg | 27 EUR |
[Thr5]-Speract / Sperm Activating Peptide |
|||
070-71 | PHOENIX PEPTIDE | 1 mg | 114.48 EUR |
Stresscopin Related Peptide (SRP) (Human) |
|||
019-27 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Gastrin Releasing Peptide (GRP) (Porcine) |
|||
027-13 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
[D-Ala1]-Peptide T - Biotin Labeled |
|||
B-057-02 | PHOENIX PEPTIDE | 100 μg | 316.44 EUR |
F3 Peptide (4-13) / HMGN2 Fragment 3 (4-13) |
|||
004-13 | PHOENIX PEPTIDE | 200 μg | 177.12 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - I-125 Labeled Purified IgG |
|||
T-G-064-01 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
PGMtide Control Peptide - Biotin Labeled |
|||
B-040-70 | PHOENIX PEPTIDE | 20 μg | 537.84 EUR |